A structural basis for constitutive activity in the human CAR/RXRα heterodimer

Molecular Cell

Volumn 16, Issue 6, 2004, Pages 919-928

  Xu, Robert X ^a   Lambert, Millard H ^a   Wisely, Bruce B ^a   Warren, Erin N ^a   Weinert, Emily E ^a   Waitt, Gregory M ^a   Williams, Jon D ^a   Collins, Jon L ^a   Moore, Linda B ^a   Willson, Timothy M ^a   Moore, John T ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSTITUTIVE ANDROSTANE RECEPTOR; RETINOID X RECEPTOR ALPHA;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING;

BINDING SITES; DIMERIZATION; HUMANS; LIGANDS; OXIMES; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RETINOID X RECEPTOR ALPHA; THIAZOLES; TRANSCRIPTION FACTORS;

EID: 19944372389     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2004.11.042     Document Type: Article

References (60)

1. Baes M., Gulick T., Choi H.S., Martinoli M.G., Simha D., Moore D.D. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol. Cell. Biol. 14:1994;1544-1551
2. Barrieren-Mackenzie A., Mata de Urquiza A., Petersson S., Rodriguez F.J., Friling S., Wagner J., Ordentlich P., Lengqvist J., Heyman R.A., Arenas E., Perlmann T. Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells. Genes Dev. 17:2003;3036-3047
3. Bourguet W., Vivat V., Wurtz J.M., Chambon P., Gronemeyer H., Moras D. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol. Cell. 5:2000;289-298
4. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.-S., Kuszewski J., Nilges M., Pannu N.S., et al. Crystallography & NMR system. a new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54:1998;905-921
5. Cavanagh J., Benson L.M., Thompson R., Naylor S. In-line desalting mass spectrometry for the study of noncovalent biological complexes. Anal. Chem. 75:2003;3281-3286
6. CCP4 The CCP4 (Collaborative Computational Project Number 4) suite. programs for protein crystallography Acta Crystallogr. D. Biol. Crystallogr. 50:1994;760-763
7. Choi H.-S., Chung M., Tzameli I., Simha D., Lee Y.-K., Seol W., Moore D.D. Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J. Biol. Chem. 272:1997;23565-23571
8. Devchand P.R., Ijpenberg A., Devesvergne B., Wahli W. Ppars. nuclear receptors for fatty acids, eicosanoids, and xenobiotics Adv. Exp. Med. Biol. 469:1999;231-236
9. Dussault I., Lin M., Hollister K., Fan M., Termini J., Sherman M.A., Forman B.M. A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity. Mol. Cell. Biol. 22:2002;5270-5280
10. Forman B.M., Tzameli I., Choi H.S., Chen J., Simha D., Seol W., Evans R.M., Moore D.D. Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature. 395:1998;612-615
11. Gampe R.T. Jr., Montana V.G., Lambert M.H., Miller A.B., Bledsoe R.K., Milburn M.V., Kliewer S.A., Willson T.M., Xu H.E. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell. 5:2000;545-555
12. Goodwin B., Hodgson E., Liddle C. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol. Pharmacol. 56:1999;1329-1339
13. Goodwin B., Moore L.B., Stoltz C.M., McKee D.D., Kliewer S.A. Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Mol. Pharmacol. 60:2001;427-431
14. Handschin C., Meyer U.A. Induction of drug metabolism. the role of nuclear receptors Pharmacol. Rev. 55:2003;649-673
15. Honkakoski P., Moore R., Washburn K.A., Negishi M. Activation by diverse xenochemicals of the 51-base pair phenobarbital-responsive enhancer module in the CYP2B10 gene. Mol. Pharmacol. 53:1998;597-601. a
16. Honkakoski P., Zelko I., Sueyoshi T., Negishi M. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital- responsive enhancer module of the CYP2B gene. Mol. Cell. Biol. 18:1998;5652-5658. b
17. Honkakoski P., Sueyoshi T., Negishi M. Drug-activated nuclear receptors CAR and PXR. Ann. Med. 35:2003;172-182
18. Huang W., Zhang J., Chua S.S., Qatanani M., Han Y., Granata R., Moore D.D. Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc. Natl. Acad. Sci. USA. 100:2003;4156-4161. Published online March 18, 2003.
19. Issa L.L., Leong G.M., Eisman J.A. Molecular mechanism of vitamin D receptor action. Inflamm. Res. 47:1998;451-475
20. Kallen J.A., Schlaeppi J.-M., Bitsch F., Geisse S., Geiser M., Delhon I., Fournier B. X-ray structure of the hRORα LBD at 1.63 Å structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORα Structure. 10:2002;1697-1707
21. Kawamoto T., Sueyoshi T., Zelko I., Moore R., Washburn K., Negishi M. Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol. Cell. Biol. 19:1999;6318-6322
22. Keppler D., Konig J. Hepatic secretion of conjugated drugs and endogenous substances. Semin. Liver Dis. 20:2000;265-272
23. Kobayashi K., Sueyoshi T., Inoue K., Moore R., Negishi M. Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells. Mol. Pharmacol. 64:2003;1069-1075
24. Kullak-Ublick G.A., Stieger B., Meier P.J. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology. 126:2004;322-342
25. Lambert M.H. Docking Conformationally Flexible Molecules into Protein Binding Sites. Charifson P.S. Practical Application of Computer-Aided Drug Design. 1997;243-303 Marcel-Dekker, New York
26. Liddle C., Goodwin B. Regulation of hepatic drug metabolism. role of the nuclear receptors PXR and CAR Semin. Liver Dis. 22:2002;115-122
27. Madauss K.P., Deng S.-J., Austin R.J.H., Lambert M.H., McLay I., Pritchard J., Short S.A., Stewart E.L., Uings I.J., Williams S.P. Progesterone receptor ligand binding pocket flexibility. crystal structures of the norethindrone and mometasone furoate complexes J. Med. Chem. 47:2004;3381-3387
28. Maglich J.M., Stoltz C.M., Goodwin B., Hawkins-Brown D., Moore J.T., Kliewer S.A. Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol. Pharmacol. 62:2002;638-646
29. Maglich J.M., Parks D.J., Moore L.B., Collins J.L., Goodwin B., Billin A.N., Stoltz C.A., Kliewer S.A., Lambert M.H., Willson T.M., Moore J.T. Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J. Biol. Chem. 278:2003;17277-17283
30. Maglich J.M., Watson J., McMillen P.J., Goodwin B., Willson T.M., Moore J.T. The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. J. Biol. Chem. 279:2004;19832-19838. Published online March 5, 2004.
31. Makishima M., Lu T.T., Xie W., Whitfield G.K., Domoto H., Evans R.M., Haussler M.R., Mangelsdorf D.J. Vitamin D receptor as an intestinal bile acid sensor. Science. 296:2002;1313-1316
32. Moore J.T., Moore L.B., Maglich J.M., Kliewer S.A. Functional and structural comparison of PXR and CAR. Biochim. Biophys. Acta. 1619:2003;235-238
33. Moore L.B., Parks D.J., Jones S.A., Bledsoe R.K., Consler T.G., Stimmel J.B., Goodwin B., Liddle C., Blanchard S.G., Willson T.M., et al. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol. Chem. 275:2000;15122-15127
34. Moore L.B., Maglich J.M., McKee D.D., Wisely B., Willson T.M., Kliewer S.A., Lambert M.H., Moore J.T. Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Mol. Endocrinol. 16:2002;977-986
35. Nicholls A., Sharp K., Honig B. Protein folding and association. insights from the interfacial and thermodynamic properties of hydrocarbons Proteins. 11:1991;281-296
36. Onate S.A., Tsai S.Y., Tsai M.-J., O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 270:1995;1354-1357
37. Otwinowski Z., Minor W. Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326
38. Rochel N., Wurtz J.M., Mitschler A., Klaholz B., Moras D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell. 5:2000;173-179
39. Rosenfeld J.M., Vargas R. Jr., Xie W., Evans R.M. Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Mol. Endocrinol. 17:2003;1268-1282
40. Saini S.P., Sonoda J., Xu L., Toma D., Uppal H., Mu Y., Ren S., Moore D.D., Evans R.M., Xie W. A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification. Mol. Pharmacol. 65:2004;292-300
41. Sakai H., Iwata H., Kim E.-Y., Tanabe S., Baba N. Identification of constitutive androstane receptor cDNA in northern fur seal (Callorhinus ursinus). Mar. Environ. Res. 58:2004;107-111
42. Shan L., Vincent J., Brunzelle J.S., Dussault I., Lin M., Ianculescu I., Sherman M.A., Forman B.M., Fernandez E.J. Structure of the murine constitutive androstane receptor complexed to androstenol. basis for inverse agonism Mol. Cell. 16:2004;907-917., this issue
43. Smirlis D., Muangmoonchai R., Edwards M., Phillips I.R., Shephard E.A. Orphan receptor promiscuity in the induction of cytochromes p450 by xenobiotics. J. Biol. Chem. 276:2001;12822-12826
44. Sobott F., Hernandez H., McCammon M.G., Tito M.A., Robinson C.V. A tandem mass spectrometer for improved transmission and analysis of large macromolecular assemblies. Anal. Chem. 74:2002;1402-1407
45. Stehlin C., Wurtz J.-M., Steinmetz A., Greiner E., Schule R., Moras D., Renaud J.-P. X-ray structure of the orphan nuclear receptor RORβ ligand-binding domain in the active conformation. EMBO J. 20:2001;5822-5831
46. Sueyoshi T., Kawamoto T., Zelko I., Honkakoski P., Negishi M. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J. Biol. Chem. 274:1999;6043-6046
47. Suino K., Peng L., Reynolds R., Li Y., Cha J.-Y., Repa J., Kliewer S.A., Xu H.E. The nuclear xenobiotic receptor CAR. structural determinants of constitutive activation and heterodimerization Mol. Cell. 16:2004;893-905., this issue
48. Svensson S., Oestberg T., Jacobsson M., Norstroem C., Stefansson K., Hallen D., Johansson I.C., Zachrisson K., Ogg D., Jendeberg L. Crystal structure of the heterodimeric complex of LXRa and RXRb ligand-binding domains in a fully agonistic conformation. EMBO J. 22:2003;4625-4633
49. Swales K., Negishi M. CAR, driving into the future. Mol. Endocrinol. 18:2004;1589-1598
50. Tzameli I., Pissios P., Schuetz E.G., Moore D.D. The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Mol. Cell. Biol. 20:2000;2951-2958
51. Tzameli I., Chua S.S., Cheskis B., Moore D.D. Complex effects of rexinoids on ligand dependent activation or inhibition of the xenobiotic receptor, CAR. Nucl. Recept. 1:2003;2
52. Ueda A., Hamadeh H.K., Webb H.K., Yamamoto Y., Sueyoshi T., Afshari C.A., Lehmann J.M., Negishi M. Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol. Pharmacol. 61:2002;1-6
53. Wang Z., Benoit G., Liu J., Prasad S., Aarnisalo P., Liu X., Xu H., Walker N.P.C., Perlmann T. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature. 423:2003;555-560
54. Watkins R.E., Wisely G.B., Moore L.B., Collins J.L., Lambert M.H., Williams S.P., Willson T.M., Kliewer S.A., Redinbo M.R. The human nuclear xenobiotic receptor PXR. structural determinants of directed promiscuity Science. 292:2001;2329-2333
55. Watkins R.E., Davis-Searles P.R., Lambert M.H., Redinbo M.R. Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. J. Mol. Biol. 331:2003;815-828. a
56. Watkins R.E., Maglich J.M., Moore L.B., Wisely G.B., Noble S.M., Davis-Searles P.R., Lambert M.H., Kliewer S.A., Redinbo M.R. 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin. Biochemistry. 42:2003;1430-1438. b
57. Williams S., Bledsoe R.K., Collins J.L., Boggs S., Lambert M.H., Miller A.B., Moore J., McKee D.D., Moore L., Nichols J., et al. X-ray crystal structure of the liver X receptor beta ligand binding domain. regulation by a histidine-tryptophan switch J. Biol. Chem. 278:2003;27138-27143
58. Willson T.M., Kliewer S.A. PXR, CAR and drug metabolism. Nat. Rev. Drug Discov. 1:2002;259-266
59. Xie W., Barwick J.L., Simon C.M., Pierce A.M., Safe S., Blumberg B., Guzelian P.S., Evans R.M. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev. 14:2000;3014-3023
60. Zucker S.D., Goessling W., Gollan J.L. Intracellular transport of small hydrophobic compounds by the hepatocyte. Semin. Liver Dis. 16:1996;159-167